Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15837-15844
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15837
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15837
Variable | Actimel group | Yakult group | P value |
n | 30 | 30 | |
Age (yr) | 69.7 ± 17.6 | 74.1 ± 17.5 | NS |
Male gender | 63.3% | 60.0% | NS |
PST 0 or 1 | 70.0% | 51.7% | NS |
BMI | 25.9 ± 4.2 | 25.1 ± 4.1 | NS |
Creatinine (mg/dL) | 1.2 ± 0.5 | 1.1 ± 0.3 | NS |
Albumin (mg/dL) | 3.4 ± 0.3 | 3.3 ± 0.3 | NS |
Diagnosis (aite of infection/aepsis) | Pulmonary: 30.0% Genitourinary: 50.0% Biliary: 3.3% Sepsis: 0.0% Diverticulitis: 0.0% Dermal: 13.3% Misc.: 3.3% | Pulmonary: 50.0% Genitourinary: 26.7% Biliary: 6.7% Sepsis: 3.3% Diverticulitis: 3.3% Dermal: 6.7% Misc.: 3.3% | NS |
Antibiotics | Ampicillin: 20.0% Cefuroxime: 20.0% Ceftriaxone: 20.0% Ciprofloxacin: 0.0% Clarithromycin: 10.0% Tazobactam: 0.0% Levofloxacin: 20.0% Moxifloxacin: 0.0% Cotrimoxazole: 3.3% Penicillin: 13.3% | Ampicillin: 36.7% Cefuroxime: 10.0% Ceftriaxone: 10.0% Ciprofloxacin: 3.3% Clarithromycin:16.7% Tazobactam: 10.0% Levofloxacin: 20.0% Moxifloxacin: 3.3% Cotrimoxazole: 6.7% Penicillin: 0.0% | NS |
Days of treatment | 6.0 ± 3.1 | 6.6 ± 3.7 | NS |
Concurrent PPI treatment | 23.3% | 50.0% | 0.06 |
Antibiotic treatment in history | 3.3% | 10.0% | NS |
-
Citation: Dietrich CG, Kottmann T, Alavi M. Commercially available probiotic drinks containing
Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol 2014; 20(42): 15837-15844 - URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15837.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15837